Extending the Platinum‐Free Interval in Recurrent Ovarian Cancer: The Role of Topotecan in Second‐Line Chemotherapy
Oncologist - United States
doi 10.1634/theoncologist.4-2-87
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 1999
Authors
Publisher
Alphamed Press